[February 08, 2016]

Diphtheria Pipeline Review, H2 2015 - Research and Markets

Research and Markets (http://www.researchandmarkets.com/research/6g29mm/diphtheria) has announced the addition of the "Diphtheria - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Diphtheria Prostate Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diphtheria Prostate Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce frst-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Diphtheria Prostate Cancer Overview
3. Therapeutics Development
4. Pipeline Products for Diphtheria Prostate Cancer - Overview
5. Pipeline Products for Diphtheria Prostate Cancer - Comparative Analysis
6. Diphtheria Prostate Cancer - Therapeutics under Development by Companies
7. Diphtheria Prostate Cancer - Therapeutics under Investigation by Universities/Institutes
8. Diphtheria Prostate Cancer - Pipeline Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Diphtheria Prostate Cancer - Products under Development by Companies
13. Diphtheria Prostate Cancer - Products under Investigation by Universities/Institutes
14. Diphtheria Prostate Cancer - Companies Involved in Therapeutics Development

• Beijing Minhai Biotechnology Co., Ltd
• Biological E. Limited
• Boryung Pharmaceutical Co., Ltd.
• Daiichi Sankyo Company, Limited
• GlaxoSmithKline Plc
• Green Cross Corporation
• Indian Immunologicals Limited
• LG Life Science LTD.
• Panacea Biotec Limited
• Prometheon Pharma, LLC
• Sanofi
• Sanofi Pasteur SA
• Serum Institute of India Limited
• Sinovac Biotech Ltd.
• Zydus Cadila Healthcare Limited

For more information visit http://www.researchandmarkets.com/research/6g29mm/diphtheria

View source version on businesswire.com: http://www.businesswire.com/news/home/20160208005598/en/

[ Back To TMCnet.com's Homepage ]